Does RISPERIDONE Cause Hyperammonaemic encephalopathy? 96 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Hyperammonaemic encephalopathy have been filed in association with RISPERIDONE (Risperidone). This represents 0.1% of all adverse event reports for RISPERIDONE.
96
Reports of Hyperammonaemic encephalopathy with RISPERIDONE
0.1%
of all RISPERIDONE reports
0
Deaths
62
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From RISPERIDONE?
Of the 96 reports, 62 (64.6%) required hospitalization, and 16 (16.7%) were considered life-threatening.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does RISPERIDONE Cause?
Gynaecomastia (24,453)
Off label use (10,376)
Abnormal weight gain (9,418)
Weight increased (6,885)
Emotional disorder (5,809)
Product use in unapproved indication (5,551)
Drug ineffective (5,232)
Injury (4,447)
Hyperprolactinaemia (4,124)
Galactorrhoea (3,513)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
VALPROATE (120)
DIVALPROEX (119)
OXALIPLATIN (107)
TOPIRAMATE (101)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
CAPECITABINE (60)
Which RISPERIDONE Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
RISPERIDONE vs RITALIN
RISPERIDONE vs RITLECITINIB
RISPERIDONE vs RITODRINE
RISPERIDONE vs RITONAVIR
RISPERIDONE vs RITUXAN